![Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT, a premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation](https://ala.associates/wp-content/uploads/2021/07/Science-Cover-Imaging.png)
![Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT, a premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation](https://ala.associates/wp-content/uploads/2021/07/Science-Cover-Imaging.png)
![Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme](https://ala.associates/wp-content/uploads/2021/06/logo_yposkesi-1080x675.jpg)
Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme
![Ferrer launches third edition of Ferrer 4 Future program](https://ala.associates/wp-content/uploads/2021/06/F4F-Header-pdf-1080x675.jpg)
Ferrer launches third edition of Ferrer 4 Future program
![Hephaï files software patent for its digital education platform designed to improve patient inhaler use](https://ala.associates/wp-content/uploads/2021/06/Illustration-de-lutilisation-dun-inhalateur-avec-analyse-des-mouvements-par-la-plateforme-Hephai-1080x675.jpg)
Hephaï files software patent for its digital education platform designed to improve patient inhaler use
![Yposkesi launches construction of its second commercial bioproduction site](https://ala.associates/wp-content/uploads/2021/06/CAM01NEW-1-1080x675.jpg)
Yposkesi launches construction of its second commercial bioproduction site
Yposkesi’s bioproduction Boost project awarded €1.2M in French government funding
![CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors](https://ala.associates/wp-content/uploads/2021/06/SonoCloud-9-Fond-Bleu-resized.png)
CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
![Advent France Biotechnology appoints Sidonie Fabre as CFO](https://ala.associates/wp-content/uploads/2021/06/Sidonie-Fabre-853x675.png)
Advent France Biotechnology appoints Sidonie Fabre as CFO
![Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate](https://ala.associates/wp-content/uploads/2021/06/EACR-STING-1080x675.png)
Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate
![Launch of OncoSTART consortium supporting oncology entrepreneurs](https://ala.associates/wp-content/uploads/2021/05/logo-OncoSTART-RVB.png)